Product Launch (Blog)

Oct, 30 2021

India Molecular Diagnostic Controls Market is Expected to grow at 13.70% in the Forecast Period of 2021 to 2028

India Molecular Diagnostic Controls Market is growing due to growing prevalence of cancer, increased investment in R&D and increased penetration of novel diagnostic products.

However, high cost of product may hamper the growth of the market.

India Molecular Diagnostic Controls market Scenario               

According to Data Bridge Market Research, the market for molecular diagnostic controls in India region has the highest CAGR in India, Africa and India Molecular Diagnostic controls market. Market leaders are Bio-Rad Laboratories Inc., and Randox Laboratories which accounts an estimated market share of approximately 30%. The company has gained outstanding sale through providing diagnostic devices and undergoing partnership

  • In June 2020, Bio-Rad Laboratories, Inc. announced that it has undergone partnership with Seegene, Inc. for the development and commercialization of infectious disease molecular diagnostic products. This partnership done by the company has increased its demand and sales in the market

India Molecular Diagnostic Controls MarketTrends Impacting the Market

The molecular diagnostic controls market is becoming more competitive with companies such as Bio-Rad Laboratories, and Thermo Fisher Scientific Inc. among others as they are the top dominating companies in molecular diagnostic controls market having maximum number of products. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the India molecular diagnostic controls market.     

For more analysis on the molecular diagnostic controls market, request for a briefing with our analysts  https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=india-molecular-diagnostic-controls-market

India Molecular Diagnostic Controls Market Developments

  • In June 2021, Bio-Rad Laboratories, Inc. announced that it has undergone partnership with Seegene, Inc. for the development and commercialization of infectious disease molecular diagnostic products. This partnership done by the company has increased its demand and sales in the market.
  • In March 2021, Randox Laboratories Ltd. announced that it has launched new product named ACUSERA D-Dimer Control. This new product launched by the company has increased its sales and demand in the market leading to increased revenue in future.

Scope of the India Molecular Diagnostic Controls Market

All country based analysis of the India molecular diagnostic controls market is further analysed based on maximum granularity into further segmentation. On the basis of product, India molecular diagnostic controls market is segmented into independent controls and instrument-specific controls. On the basis of analyte, India molecular diagnostic controls market is segmented into single-analyte controls and multi-analyte controls. On the basis of application, India molecular diagnostic controls market is segmented into infectious diseases, oncology, genetic testing and other applications. On the basis of end user, India molecular diagnostic controls market is segmented into clinical laboratories, hospitals, IVD manufacturers and contract research organizations, academic & research institutes, and other end users. On the basis of distribution channel, India molecular diagnostic controls market is segmented into direct tender and retail sales.

To know more about the study https://www.databridgemarketresearch.com/reports/india-molecular-diagnostic-controls-market

Key Pointers Covered in India Molecular Diagnostic Controls Market Industry Trends and Forecast to 2028

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries

Key Market Competitors Covered in the Report

  • Bio-Rad Laboratories Inc.
  • Randox Laboratories
  • Abbott
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Molbio Diagnostics Pvt. Ltd.
  • SERACARE LIFE SCIENCES
  • Asuragen, Inc.

Above are the key players covered in the report, to know about more and exhaustive list of swabs collection kits market companies, contact us https://www.databridgemarketresearch.com/toc/?dbmr=india-molecular-diagnostic-controls-market

Research Methodology: India Molecular Diagnostic Controls Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Clinicians, Healthcare Professionals, Researchers, Academician.
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/

 


Client Testimonials